Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 56,355 | 49,678 | 46,015 | 42,034 | 35,141 |
| Operating Income | -56,355 | -49,678 | -46,015 | -42,034 | -35,141 |
| Interest Expense | 70 | 35 | 40 | 43 | 1,748 |
| Other Income | 5,279 | 5,098 | 4,929 | 2,883 | 1,486 |
| Pre-tax Income | -51,146 | -44,615 | -41,126 | -39,194 | -35,403 |
| Net Income Continuous | -51,146 | -44,615 | -41,126 | -39,194 | -35,403 |
| Net Income | $-51,146 | $-44,615 | $-41,126 | $-39,194 | $-35,403 |
| EPS Basic Total Ops | -0.73 | -0.64 | -0.59 | -0.63 | -0.58 |
| EPS Basic Continuous Ops | -0.73 | -0.64 | -0.59 | -0.62 | -0.58 |
| EPS Diluted Total Ops | -0.73 | -0.64 | -0.59 | -0.63 | -0.58 |
| EPS Diluted Continuous Ops | -0.73 | -0.64 | -0.59 | -0.62 | -0.58 |
| EBITDA(a) | $-60,011 | $-53,393 | $-49,979 | $-44,056 | $-36,170 |